← Back to Screener
CryoPort, Inc. Common Stock (CYRX)
Price$10.17
Favorite Metrics
Price vs S&P 500 (26W)-3.89%
Price vs S&P 500 (4W)18.19%
Market Capitalization$501.05M
P/E Ratio (Annual)6.40x
All Metrics
Book Value / Share (Quarterly)$10.08
P/TBV (Annual)1.32x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-9.45%
Cash Flow / Share (Quarterly)$-0.56
Price vs S&P 500 (YTD)2.25%
Gross Margin (TTM)47.14%
Net Profit Margin (TTM)42.35%
EPS (TTM)$1.48
10-Day Avg Trading Volume0.45M
EPS Excl Extra (TTM)$1.48
Revenue Growth (5Y)17.49%
EPS (Annual)$1.56
ROI (Annual)11.35%
Gross Margin (Annual)47.14%
Net Profit Margin (5Y Avg)-37.60%
Cash / Share (Quarterly)$8.25
P/E Basic Excl Extra (TTM)6.72x
Revenue Growth QoQ (YoY)-23.65%
P/E Normalized (Annual)6.40x
ROA (Last FY)10.24%
Revenue Growth TTM (YoY)-22.86%
EBITD / Share (TTM)$-0.24
ROE (5Y Avg)-16.59%
Operating Margin (TTM)-20.89%
Cash Flow / Share (Annual)$-0.56
P/B Ratio1.00x
P/B Ratio (Quarterly)0.96x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.49x
Net Interest Coverage (TTM)-194.57x
ROA (TTM)9.91%
EV / EBITDA (TTM)6258.10x
EPS Incl Extra (Annual)$1.56
Current Ratio (Annual)2.17x
Quick Ratio (Quarterly)2.03x
3-Month Avg Trading Volume0.42M
52-Week Price Return77.92%
P/E Incl Extra (TTM)6.72x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$7.31
P/S Ratio (Annual)2.84x
Asset Turnover (Annual)0.23x
52-Week High$11.45
Operating Margin (5Y Avg)-48.26%
EPS Excl Extra (Annual)$1.56
CapEx CAGR (5Y)15.07%
Tangible BV CAGR (5Y)16.65%
26-Week Price Return0.10%
Quick Ratio (Annual)2.03x
13-Week Price Return-5.45%
Total Debt / Equity (Annual)0.37x
Current Ratio (Quarterly)2.17x
Enterprise Value$438.067
Revenue / Share Growth (5Y)11.53%
Asset Turnover (TTM)0.23x
Book Value / Share Growth (5Y)0.95%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.08x
Pretax Margin (Annual)-18.26%
Cash / Share (Annual)$8.25
3-Month Return Std Dev44.22%
Gross Margin (5Y Avg)39.42%
Net Income / Employee (TTM)$0
ROE (Last FY)15.58%
Net Interest Coverage (Annual)-16.12x
EPS Basic Excl Extra (Annual)$1.56
Receivables Turnover (TTM)4.45x
Total Debt / Equity (Quarterly)0.37x
EPS Incl Extra (TTM)$1.48
Receivables Turnover (Annual)4.45x
ROI (TTM)11.08%
P/S Ratio (TTM)2.84x
Pretax Margin (5Y Avg)-47.57%
Revenue / Share (Annual)$3.52
Tangible BV / Share (Annual)$7.31
Forward P/E6.12x
Price vs S&P 500 (52W)48.09%
P/E Ratio (TTM)6.72x
Year-to-Date Return4.90%
5-Day Price Return3.18%
EPS Normalized (Annual)$1.56
ROA (5Y Avg)-8.96%
Net Profit Margin (Annual)44.44%
Month-to-Date Return21.62%
Cash Flow / Share (TTM)$-0.59
EBITD / Share (Annual)$-0.24
Operating Margin (Annual)-20.89%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-9.86%
P/E Excl Extra (TTM)6.72x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$1.48
P/TBV (Quarterly)1.32x
P/B Ratio (Annual)0.96x
Inventory Turnover (TTM)4.08x
Pretax Margin (TTM)-18.26%
Book Value / Share (Annual)$10.08
Price vs S&P 500 (13W)-6.13%
Beta1.74x
Revenue / Share (TTM)$3.53
ROE (TTM)15.46%
52-Week Low$5.21
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.27
4.27
4.27
4.25
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CYRXCryoPort, Inc. Common Stock | 2.84x | -22.86% | 47.14% | — | $10.17 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Cryoport is a provider of integrated temperature-controlled logistics and products for the life sciences industry, serving biopharmaceutical, pharmaceutical, animal health, and reproductive medicine markets. The company operates two business segments: Life Sciences Services and Life Sciences Products. With global operations across the Americas, Europe, the Middle East, Africa, and Asia Pacific, Cryoport generates the majority of its revenue from North American operations.